What causes bws syndrome

What is Beckwith-Wiedemann Syndrome (BWS)?

Beckwith-Wiedemann syndrome (BWS) is a complex congenital disorder characterized by excessive growth from birth. It is one of the most common overgrowth syndromes, affecting approximately 1 in 10,500 live births globally. Individuals with BWS typically exhibit a range of physical characteristics, though the severity and combination of these features can vary significantly from person to person. The syndrome is named after the two physicians, Dr. John R. Beckwith and Dr. H. Bruce Wiedemann, who independently described it in 1964 and 1965, respectively.

What Causes Beckwith-Wiedemann Syndrome?

The underlying cause of BWS is rooted in genetic abnormalities, specifically related to genomic imprinting. Genomic imprinting is a phenomenon where certain genes are expressed in a parent-of-origin-specific manner. This means that for these genes, only the copy inherited from either the mother or the father is active, while the other copy is silenced. BWS arises from disruptions in the normal imprinting patterns within a critical region on the short arm of chromosome 11, known as 11p15.5. This region contains a cluster of genes involved in regulating growth and development.

Genetic Mechanisms of BWS

Several distinct genetic mechanisms can lead to BWS, all affecting the imprinting status of genes in the 11p15.5 region:

• Loss of methylation at the ICR1 (Imprinting Control Region 1): This is the most common cause, accounting for about 50% of BWS cases. ICR1 is normally methylated on the paternal chromosome, which leads to the activation of growth-promoting genes (like IGF2) and the silencing of growth-inhibiting genes (like CDKN1C) on that chromosome. When ICR1 loses its paternal methylation, it mimics a maternal imprinting pattern, leading to overexpression of IGF2 and underexpression of CDKN1C, resulting in overgrowth.
• Gain of methylation at the ICR2 (Imprinting Control Region 2): This accounts for about 30-40% of BWS cases. ICR2 is normally unmethylated on the maternal chromosome, leading to the expression of certain genes. When ICR2 gains methylation on the maternal chromosome, it silences these genes, leading to a growth imbalance.
• Mutations in CDKN1C: In about 5-10% of cases, BWS is caused by a mutation in the CDKN1C gene itself, which is located within the 11p15.5 region. CDKN1C is a tumor suppressor gene that normally inhibits cell proliferation. A mutation in this gene can lead to its reduced function, contributing to overgrowth and an increased risk of tumors.
• Maternal uniparental disomy of chromosome 11: In rare instances (less than 1%), an individual inherits two copies of chromosome 11 from their mother and no copy from their father. Since the critical genes in the 11p15.5 region are imprinted in a parent-of-origin-specific manner, having two maternal copies can lead to an imbalance in gene expression, causing BWS.
• Other rare genetic alterations: Less common causes include deletions or duplications within the 11p15.5 region or mutations in other imprinted genes.

Sporadic vs. Familial BWS

While the genetic mechanisms are the same, the origin of the genetic change differs:

• Sporadic Cases: Approximately 85% of BWS cases occur sporadically. This means the genetic alteration arises by chance in the egg or sperm cell just before conception, or very early in embryonic development. These individuals do not typically have a family history of BWS, and the risk of recurrence in future pregnancies for their parents is very low.
• Familial Cases: In about 15% of cases, BWS is familial, meaning the genetic predisposition is inherited from one of the parents. A parent with a balanced chromosomal rearrangement affecting the 11p15.5 region, or a subtle imprinting defect, might pass on an unbalanced contribution to their child, resulting in BWS. If BWS is familial, there is a higher risk of recurrence in subsequent pregnancies.

Key Features Associated with BWS

The genetic changes leading to BWS disrupt the delicate balance of growth regulation, resulting in several characteristic features:

• Overgrowth: This is a hallmark of BWS, often evident prenatally and continuing postnatally. It can manifest as increased birth weight, a larger-than-average head circumference (macrocephaly), and lengthening of limbs (hemihyperplasia).
• Abdominal Wall Defects: Omphalocele (a condition where abdominal organs protrude through an opening in the abdominal wall) and diastasis recti (separation of the abdominal muscles) are common.
• Macroglossia: An enlarged tongue is frequently observed, which can cause feeding difficulties, breathing problems, and speech issues.
• Visceromegaly: Enlargement of internal organs, such as the liver, spleen, and kidneys, can occur.
• Increased risk of childhood cancers: Individuals with BWS have a significantly higher risk of developing certain childhood cancers, most notably Wilms tumor (a kidney cancer), hepatoblastoma (a liver cancer), and neuroblastoma. Regular screening is crucial for early detection.
• Other features: Earlobe creases or pits, facial features like a prominent forehead or a specific groove in the earlobe, and hypoglycemia (low blood sugar) in newborns are also associated with BWS.

Understanding the genetic basis of BWS is crucial for diagnosis, genetic counseling, and managing the associated health risks, particularly the predisposition to cancer.